645 studies found for:    chelation
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Completed Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia
Conditions: Systemic Inflammation;   Iron Loading;   Iron Chelation
Interventions: Drug: iron sucrose;   Drug: Deferasirox;   Drug: endotoxin;   Drug: Placebo
3 Not yet recruiting An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Condition: Beta Thalassemia Major
Intervention: Drug: Deferiprone
4 Not yet recruiting Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Conditions: Vitamin c;   Thalassemia Major;   Iron Chelation
Interventions: Drug: Vitamin C, Defriprone, deferisarox;   Drug: deferiprone , deferesarox
5 Completed Combo Chelation Trial
Conditions: Thalassemia;   Iron Overload
Intervention: Drug: Combo Chelation with Deferasirox (Exjade) and Desferal (DFO)
6 Completed
Has Results
Trial to Assess Chelation Therapy (TACT)
Condition: Coronary Artery Disease
Interventions: Drug: EDTA;   Drug: EDTA Placebo;   Dietary Supplement: High Dose Vitamin;   Dietary Supplement: High Dose Vitamin Placebo
7 Completed Combination Iron Chelation Therapy
Conditions: Iron Overload;   Thalassemia
Intervention: Drug: Combination Iron Chelation Therapy
8 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
9 Completed Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition: Urologic Disease
Intervention: Drug: calcium disodium EDTA (edetate calcium disodium)
10 Withdrawn Penicillamine Chelation for Children With Lead Poisoning
Conditions: Lead Poisoning;   Vitamin D Deficiency
Interventions: Device: d-penicillamine;   Drug: placebo
11 Recruiting Amlodipine for Myocardial Iron in Thalassemia
Condition: Thalassemia
Interventions: Drug: Deferasirox or Deferoxamine or Combination (Deferoxamine and Deferiprone);   Drug: Amlodipine
12 Completed Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
Conditions: Iron Overload;   Cardiomyopathy
Interventions: Drug: Deferoxamine and Deferiprone;   Drug: Deferoxamine
13 Unknown  Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis
Conditions: Anemia;   Malnutrition;   Inflammation;   Lead Poisoning
Intervention: Drug: lead chelation therapy
14 Withdrawn Mercury Chelation to Treat Autism
Conditions: Autism;   Asperger's Disorder;   Child Development Disorders, Pervasive
Intervention: Drug: DMSA
15 Completed
Has Results
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Conditions: Anemia;   Hemosiderosis
Intervention: Drug: Deferasirox
16 Completed
Has Results
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload in β-thalassemia
Intervention: Drug: Deferasirox
17 Withdrawn Treatment of Iron Overload Requiring Chelation Therapy
Conditions: Transfusional Iron Overload;   Iron Overload;   Iron Chelation;   Beta-thalassemia;   Transfusional Hemosiderosis;   Iron Metabolism Disorders;   Metabolic Diseases
Interventions: Drug: SPD602;   Drug: Deferasirox
18 Terminated
Has Results
Stroke With Transfusions Changing to Hydroxyurea
Conditions: Hemochromatosis;   Cerebrovascular Accident;   Anemia, Sickle Cell;   Hematologic Diseases
Interventions: Procedure: Red Cell Transfusions;   Procedure: Iron Chelation;   Drug: Hydroxyurea;   Procedure: Phlebotomy
19 Completed Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
Conditions: Anemia (Iron-Loading);   Beta-Thalassemia;   Hematologic Diseases;   Hemoglobinopathies;   Thalassemia;   Iron Overload
Intervention: Drug: chelation therapy
20 Completed Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload
Intervention: Drug: Deferasirox

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years